Dosing of antimicrobials in obesity: Difference between revisions
From IDWiki
(→) |
(→) |
||
Line 31: | Line 31: | ||
{| class="wikitable" |
{| class="wikitable" |
||
! Drug !! Usual Dose !! Obesity !! |
! Drug !! Usual Dose !! Obesity !! Notes |
||
|- |
|- |
||
| [[Amoxicillin]] |
| [[Amoxicillin]] |
||
| 250-500 mg q8h |
|||
⚫ | |||
| 1 g PO q8h |
| 1 g PO q8h |
||
| |
| |
||
|- |
|- |
||
| [[Ampicillin]] |
| [[Ampicillin]] |
||
| 1-2 g q4-6h |
|||
⚫ | |||
| 2 g IV q4h |
| 2 g IV q4h |
||
| |
| |
||
Line 46: | Line 46: | ||
| |
| |
||
| 2 g IV q4h |
| 2 g IV q4h |
||
| |
| |
||
|- |
|- |
||
| [[Piperacillin-tazobactam]] |
| [[Piperacillin-tazobactam]] |
||
| 4.5 g IV |
| 4.5 g IV q8h (q6h for ''Pseudomonas'') |
||
| Prolonged infusion |
| Prolonged infusion |
||
⚫ | |||
| 18 g daily |
|||
|} |
|} |
||
Line 61: | Line 61: | ||
| 1-2 g IV q8h |
| 1-2 g IV q8h |
||
| 2-3 g IV q6-8h |
| 2-3 g IV q6-8h |
||
⚫ | |||
| No data; 12 g daily |
|||
|- |
|- |
||
| [[Cephalexin]] |
| [[Cephalexin]] |
||
| 500-1000 g PO qid |
| 500-1000 g PO qid |
||
| 1000 g PO qid |
| 1000 g PO qid |
||
| |
| |
||
|- |
|- |
||
| [[Cefipime]] |
| [[Cefipime]] |
||
| 2 g IV q8h |
| 2 g IV q8h |
||
| 2 g IV q8h prolonged infusion |
| 2 g IV q8h prolonged infusion |
||
⚫ | |||
| 2 g IV q8h prolonged infusion |
|||
|- |
|- |
||
| [[Ceftazidime]] |
| [[Ceftazidime]] |
||
| 2 g IV q8h |
| 1-2 g IV q8h |
||
| 2 g IV q8h prolonged infusion |
|||
| 2 g IV q8h prolonged infusion |
| 2 g IV q8h prolonged infusion |
||
⚫ | |||
|- |
|- |
||
| [[Ceftazidime-avibactam]] |
| [[Ceftazidime-avibactam]] |
||
Line 90: | Line 90: | ||
| [[Ceftaroline]] |
| [[Ceftaroline]] |
||
| |
| |
||
| Consider |
| Consider q8h |
||
| |
| |
||
|} |
|} |
||
Line 96: | Line 96: | ||
==== Carbapenems ==== |
==== Carbapenems ==== |
||
{| class="wikitable" |
{| class="wikitable" |
||
! Drug !! Usual Dose !! Obesity !! |
! Drug !! Usual Dose !! Obesity !! Notes |
||
|- |
|- |
||
| [[Doripenem]] |
| [[Doripenem]] |
||
Line 114: | Line 114: | ||
|- |
|- |
||
| [[Meropenem]] |
| [[Meropenem]] |
||
| 500 mg q6h (1 g IV q8h for febrile neutropenia) |
|||
⚫ | |||
| Consider prolonged infusion |
| Consider prolonged infusion |
||
| |
| |
||
Line 121: | Line 121: | ||
=== Quinolones === |
=== Quinolones === |
||
{| class="wikitable" |
{| class="wikitable" |
||
! Drug !! Usual Dose !! Obesity !! |
! Drug !! Usual Dose !! Obesity !! Notes |
||
|- |
|- |
||
| [[Ciprofloxacin]] |
| [[Ciprofloxacin]] |
||
Line 129: | Line 129: | ||
|- |
|- |
||
| [[Levofloxacin]] |
| [[Levofloxacin]] |
||
| 750 mg PO q24h |
| 500-750 mg PO q24h |
||
| Consider up to 1000 mg PO q24h |
| Consider up to 1000 mg PO q24h |
||
| |
| |
||
|- |
|- |
||
| [[Moxifloxacin]] |
| [[Moxifloxacin]] |
||
| 400 mg q24h |
|||
⚫ | |||
| Usual dose |
| Usual dose |
||
| |
| |
||
Line 141: | Line 141: | ||
=== Macrolides === |
=== Macrolides === |
||
{| class="wikitable" |
{| class="wikitable" |
||
! Drug !! Usual Dose !! Obesity !! |
! Drug !! Usual Dose !! Obesity !! Notes |
||
|} |
|} |
||
=== Tetracyclines === |
=== Tetracyclines === |
||
{| class="wikitable" |
{| class="wikitable" |
||
! Drug !! Usual Dose !! Obesity !! |
! Drug !! Usual Dose !! Obesity !! Notes |
||
|} |
|} |
||
=== Aminoglycosides === |
=== Aminoglycosides === |
||
{| class="wikitable" |
{| class="wikitable" |
||
! Drug !! Usual Dose !! Obesity !! |
! Drug !! Usual Dose !! Obesity !! Notes |
||
|- |
|- |
||
| [[Amikacin]] |
| [[Amikacin]] |
||
Line 171: | Line 171: | ||
=== Others === |
=== Others === |
||
{| class="wikitable" |
{| class="wikitable" |
||
! Drug !! Usual Dose !! Obesity !! |
! Drug !! Usual Dose !! Obesity !! Notes |
||
|- |
|- |
||
| [[Aztreonam]] |
| [[Aztreonam]] |
||
Line 179: | Line 179: | ||
|- |
|- |
||
| [[Colistin]] |
| [[Colistin]] |
||
| 5 mg CBA/kg IBW x1 loading (max 300 mg) followed by 5 mg/kg/day divided q8h |
|||
| |
|||
| Use IBW |
| Use IBW |
||
| 360 mg daily (nephrotoxicity) |
| Max 360 mg daily (nephrotoxicity) |
||
|- |
|- |
||
| [[Polymyxin B]] |
| [[Polymyxin B]] |
||
| |
| |
||
| Use ABW<sub>0/4</sub> |
| Use ABW<sub>0/4</sub> |
||
| 200 mg or 2 MU daily (toxicity) |
| Max 200 mg or 2 MU daily (toxicity) |
||
|- |
|- |
||
| [[Clindamycin]] |
| [[Clindamycin]] |
||
| 300-450 mg PO q6-8h<br/>600-900 mg IV q8h |
|||
| |
|||
| 600 mg IV q6h<br/>900 mg IV q8h<br/>450-600 mg PO q6h<br/>600-900 mg PO q8h |
| 600 mg IV q6h<br/>900 mg IV q8h<br/>450-600 mg PO q6h<br/>600-900 mg PO q8h |
||
| 2700 mg daily |
| Max 2700 mg daily, or 4800 mg daily IV if life-threatening |
||
|- |
|- |
||
| [[Dalbavancin]] |
| [[Dalbavancin]] |
||
Line 199: | Line 199: | ||
|- |
|- |
||
| [[Daptomycin]] |
| [[Daptomycin]] |
||
| 4-6 mg/kg q24h |
|||
| |
|||
| Use ABW<sub>0.4</sub> |
| Use ABW<sub>0.4</sub> |
||
| |
| |
||
Line 213: | Line 213: | ||
| |
| |
||
|- |
|- |
||
| [[ |
| [[TMP-SMX]] |
||
| Up to 320 mg(TMP) PO q12h<br/>8-10 mg(TMP)/kg<sub>ABW</sub> in divided doses |
| Up to 320 mg(TMP) PO q12h<br/>8-10 mg(TMP)/kg<sub>ABW</sub> in divided doses |
||
| Consider ABW<sub>0.4</sub> when doing high dose |
| Consider ABW<sub>0.4</sub> when doing high dose |
Revision as of 16:43, 9 December 2019
Calculating Body Weight
Statistic | Equation (Male) | Equation (Female) | Notes |
---|---|---|---|
Body mass index (BMI) (kg/m2) | kg and m | ||
Body surface area (BSA) (m2) | kg and cm | ||
Ideal body weight (IBW) (kg) | in inches | ||
Adjusted body weight (ABW) (kg) | C = 0.3 to 0.4 | ||
Lean body weight (LBW) (kg) |
Antibiotics
β-lactams
Penicillins
Drug | Usual Dose | Obesity | Notes |
---|---|---|---|
Amoxicillin | 250-500 mg q8h | 1 g PO q8h | |
Ampicillin | 1-2 g q4-6h | 2 g IV q4h | |
Nafcillin | 2 g IV q4h | ||
Piperacillin-tazobactam | 4.5 g IV q8h (q6h for Pseudomonas) | Prolonged infusion |
Cephalosporins
Drug | Usual Dose | Obesity | Max dose |
---|---|---|---|
Cefazolin | 1-2 g IV q8h | 2-3 g IV q6-8h | |
Cephalexin | 500-1000 g PO qid | 1000 g PO qid | |
Cefipime | 2 g IV q8h | 2 g IV q8h prolonged infusion | |
Ceftazidime | 1-2 g IV q8h | 2 g IV q8h prolonged infusion | |
Ceftazidime-avibactam | Usual dose | ||
Ceftolozane-tazobactam | Usual dose | ||
Ceftaroline | Consider q8h |
Carbapenems
Drug | Usual Dose | Obesity | Notes |
---|---|---|---|
Doripenem | Consider extended infusion | ||
Ertapenem | 1 g IV q24h | Usual dose | |
Imipenem | Usual dose | ||
Meropenem | 500 mg q6h (1 g IV q8h for febrile neutropenia) | Consider prolonged infusion |
Quinolones
Drug | Usual Dose | Obesity | Notes |
---|---|---|---|
Ciprofloxacin | 500-750 mg PO q12h or 400 mg IV q6-8h | 400 mg IV q8h or 750 mg PO q12h | |
Levofloxacin | 500-750 mg PO q24h | Consider up to 1000 mg PO q24h | |
Moxifloxacin | 400 mg q24h | Usual dose |
Macrolides
Drug | Usual Dose | Obesity | Notes |
---|
Tetracyclines
Drug | Usual Dose | Obesity | Notes |
---|
Aminoglycosides
Drug | Usual Dose | Obesity | Notes |
---|---|---|---|
Amikacin | Use ABW0.4 | ||
Gentamicin | Use ABW0.4 | ||
Tobramycin | Use ABW0.4 |
Others
Drug | Usual Dose | Obesity | Notes |
---|---|---|---|
Aztreonam | 2 g IV q6-8h | ||
Colistin | 5 mg CBA/kg IBW x1 loading (max 300 mg) followed by 5 mg/kg/day divided q8h | Use IBW | Max 360 mg daily (nephrotoxicity) |
Polymyxin B | Use ABW0/4 | Max 200 mg or 2 MU daily (toxicity) | |
Clindamycin | 300-450 mg PO q6-8h 600-900 mg IV q8h |
600 mg IV q6h 900 mg IV q8h 450-600 mg PO q6h 600-900 mg PO q8h |
Max 2700 mg daily, or 4800 mg daily IV if life-threatening |
Dalbavancin | Usual dose | ||
Daptomycin | 4-6 mg/kg q24h | Use ABW0.4 | |
Linezolid | 600 mg PO/IV q12h | Usual dose | |
Oritavancin | Usual dose | ||
TMP-SMX | Up to 320 mg(TMP) PO q12h 8-10 mg(TMP)/kgABW in divided doses |
Consider ABW0.4 when doing high dose | |
Telavancin | Usual dose | ||
Tigecycline | Usual dose | ||
Vancomycin | 20-25 mg/kg load (max 2.5 g) 10-15 mg/kg q12h (maintenance) |
Use TBW; or 25-30 mg/kg load and 15 mg/kg q12h with ABW0.4 |
Further Reading
- Comprehensive Guidance for Antibiotic Dosing in Obese Adults. Pharmacotherapy. 2017;37(11):1415-1431. doi: 10.1002/phar.2023